marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
why novartis� landmark cancer drug approval is great news for bluebird.
. here are 4 mass. biotechs making noise at the ash conference so far.
.county grand jury report finds shortcomings in hepatitis response.
email.
.
.